24 pharma units functional in J&K under NCSS

No bulk drug, medical device parks yet

Irfan Tramboo
SRINAGAR, Mar 25: A total of 29 pharmaceutical units have been granted registration in Jammu and Kashmir under the New Central Sector Scheme (NCSS) 2021 for Industrial Development, of which 24 units have commenced operations, the Government informed the Parliament today.
According to information provided by the Department for Promotion of Industry and Internal Trade DPIIT, incentives amounting to Rs 31.76 crore have been disbursed under NCSS during the financial year 2025-26.
Under the Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs), Drug Intermediates (Dis) and Active Pharmaceutical Ingredients (APIs)-commonly referred to as the bulk drugs scheme-one project has been approved in the Union Territory.
The project has attracted an investment of Rs 162.01 crore till December 2025. However, no incentives have been released to the unit so far, the Government said.
Under the PLI Scheme for Pharmaceuticals, manufacturing has commenced in one unit in J&K, with a total investment of Rs 14.15 crore recorded till December 2025.
Despite these developments, the Government acknowledged gaps in key infrastructure within the Union Territory.
It said that no Medical Devices Park has been established in J&K so far.
Under the central scheme for promotion of medical device parks, three such parks are currently at an advanced stage of development in Greater Noida Uttar Pradesh, Ujjain Madhya Pradesh and Kanchipuram Tamil Nadu.
These parks, with a combined project cost of Rs 871.11 crore, are being supported with central assistance of Rs 100 crore each to create common infrastructure facilities and improve industry competitiveness.
Similarly, no Bulk Drug Park has been sanctioned for J&K.
The scheme, approved by the Union Cabinet in March 2020, envisages the establishment of three bulk drug parks across the country to bring down manufacturing costs through shared infrastructure and economies of scale.
The approved parks are located in Andhra Pradesh, Gujarat and Himachal Pradesh, with central financial assistance of up to Rs 1,000 crore per park, or 70 per cent of project cost 90 per cent for North-Eastern and Himalayan states, whichever is lower.
The Government said that these initiatives collectively aim to promote local production of APIs and intermediates, strengthen supply chains and provide fiscal incentives tailored to regions like J&K.
The information was provided by Minister of State for Chemicals and Fertilizers Anupriya Patel in a written reply in the Rajya Sabha.